Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slevin

Showing results (501-510 of 892) with videos related to

Pageof 90
Sort By:
Angiogenesis|March 12, 2008
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesisS Hussain, M Slevin, S Matou, et al.
BMJ (Clinical Research Ed.)|September 10, 1988
BACUP--the first two years: evaluation of a national cancer information serviceM L Slevin, Y Terry, N Hallett, et al.
Medical and Pediatric Oncology|January 1, 1982
A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemiaM L Slevin, A Z Rohatiner, H S Dhaliwal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2006
Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathwaysMark Slevin, Jurek Krupinski, John Gaffney, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.
Clinical Case Reports|July 11, 2018
Reversible manifestations of extraparenchymal neurocysticercosisEdison M Campos, Flavius D Raslau, Robert Salinas, et al.
The Medical Journal of Australia|October 22, 2014
Optimising the expansion of the National Bowel Cancer Screening ProgramDayna R Cenin, D James B St John, Melissa J N Ledger, et al.
Drug and Alcohol Review|October 11, 2018
Attitudinal and behavioural responses to increasing tobacco control regulation among high smoking prevalence groups: A qualitative studyAshleigh Parnell, Emily Box, Nicole Biagioni, et al.
British Journal of Clinical Pharmacology|October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemiaM L Slevin, E M Piall, G W Aherne, et al.
Pageof 90

Showing results (501-510 of 892) with videos related to

Sort By:
Pageof 90
Angiogenesis|March 12, 2008
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesisS Hussain, M Slevin, S Matou, et al.
BMJ (Clinical Research Ed.)|September 10, 1988
BACUP--the first two years: evaluation of a national cancer information serviceM L Slevin, Y Terry, N Hallett, et al.
Medical and Pediatric Oncology|January 1, 1982
A comparison of two schedules of cytosine arabinoside used in combination with adriamycin and 6-thioguanine in the treatment of acute myelogenous leukemiaM L Slevin, A Z Rohatiner, H S Dhaliwal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 24, 2006
Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathwaysMark Slevin, Jurek Krupinski, John Gaffney, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.
Clinical Case Reports|July 11, 2018
Reversible manifestations of extraparenchymal neurocysticercosisEdison M Campos, Flavius D Raslau, Robert Salinas, et al.
The Medical Journal of Australia|October 22, 2014
Optimising the expansion of the National Bowel Cancer Screening ProgramDayna R Cenin, D James B St John, Melissa J N Ledger, et al.
Drug and Alcohol Review|October 11, 2018
Attitudinal and behavioural responses to increasing tobacco control regulation among high smoking prevalence groups: A qualitative studyAshleigh Parnell, Emily Box, Nicole Biagioni, et al.
British Journal of Clinical Pharmacology|October 1, 1981
The pharmacokinetics of subcutaneous cytosine arabinoside in patients with acute myelogenous leukaemiaM L Slevin, E M Piall, G W Aherne, et al.
Pageof 90